While there was some company-specific news, it appears the broader economic and regulatory developments ultimately drove the stocks higher. Today marked the second day of gains after Chinese officials responded to widespread demonstrations in China to protest lockdowns resulting from the government's zero-COVID policy. In a press conference on Tuesday, government health authorities announced steps to increase the vaccination rate among China's elderly population.
Based on the average brokerage recommendation (ABR), Alibaba (BABA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Chinese government steps up push to use Risc-V in move aimed at boosting domestic production of semiconductors